» Articles » PMID: 17566676

Time-dependent Changes in Opsonin Amount Associated on Nanoparticles Alter Their Hepatic Uptake Characteristics

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2007 Jun 15
PMID 17566676
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between the time-dependent change in serum proteins adsorbed on nanoparticles and their disposition to the liver was investigated by employing lecithin-coated polystyrene nanosphere with a size of 50 nm (LNS-50) as a model nanoparticle in rats. The total amount of proteins adsorbed on LNS-50 increased and the qualitative profile of serum proteins adsorbed on LNS-50 changed during the incubation with serum up to 360 min. The liver perfusion study indicated that the hepatic uptake of LNS-50 incubated with serum for 360 min was significantly larger than those of LNS-50 incubated for shorter period. It was suggested that the increase in the hepatic uptake of LNS-50 with the increase in incubation time would be ascribed mainly to the increase in the opsonin-mediated uptake by Kupffer cells. Semi-quantification of major opsonins, complement C3 (C3) and immunoglobulin G (IgG), and in vitro uptake study in primary cultured Kupffer cells demonstrated that the increase in C3 and IgG amounts adsorbed on LNS-50 was directly reflected in the increased disposition of LNS-50 to Kupffer cells. These results indicate that the amounts of opsonins associated on nanoparticles would change over time and this process would be substantially reflected in the alteration of their hepatic disposition characteristics.

Citing Articles

Inflammatory disease progression shapes nanoparticle biomolecular corona-mediated immune activation profiles.

Shaw J, Caprio N, Truong N, Weldemariam M, Tran A, Pilli N Nat Commun. 2025; 16(1):924.

PMID: 39843415 PMC: 11754911. DOI: 10.1038/s41467-025-56210-4.


Physicochemical Property Effects on Immune Modulating Polymeric Nanoparticles: Potential Applications in Spinal Cord Injury.

Kolpek D, Kim J, Mohammed H, Gensel J, Park J Int J Nanomedicine. 2024; 19:13357-13374.

PMID: 39691455 PMC: 11649979. DOI: 10.2147/IJN.S497859.


Label free tracking to quantify nanoparticle diffusion through biological media.

Schleyer G, Patterson E, Curran J Sci Rep. 2024; 14(1):18822.

PMID: 39138253 PMC: 11322355. DOI: 10.1038/s41598-024-69506-0.


Biocompatible and bioactivable terpolymer-lipid-MnO Nanoparticle-based MRI contrast agent for improving tumor detection and delineation.

Yen T, Abbasi A, He C, Lip H, Park E, Amini M Mater Today Bio. 2024; 25:100954.

PMID: 38304342 PMC: 10832465. DOI: 10.1016/j.mtbio.2024.100954.


In vivo Biodistribution and Clearance of Magnetic Iron Oxide Nanoparticles for Medical Applications.

Nowak-Jary J, Machnicka B Int J Nanomedicine. 2023; 18:4067-4100.

PMID: 37525695 PMC: 10387276. DOI: 10.2147/IJN.S415063.